Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion

Contraception

Volumn 76, Issue 2, 2007, Pages 101-104

  Grossman, Daniel ^a   Berdichevsky, Karla ^b   Larrea, Fernando ^c   Beltran, Jorge ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b POPULATION COUNCIL   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Abortion; hCG; Sensitivity and specificity; Urine pregnancy test

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ABORTION; ADULT; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; PREGNANCY TEST; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ABORTION, INDUCED; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; PREGNANCY; PREGNANCY TESTS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 34447542532     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.04.008     Document Type: Article

References (16)

1. von Hertzen H., Honkanen H., Piaggio G., et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion: I. Efficacy. BJOG 110 (2003) 808-818
2. Coyaji K., Elul B., Krishna U., et al. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception 66 (2002) 33-40
3. Ngoc N.T., Nhan V.Q., Blum J., Mai T.T., Durocher J.M., and Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG 111 (2004) 814-819
4. Prine L.W., and Lesnewski R. Medication abortion and family physicians' scope of practice. J Am Board Fam Pract 18 (2005) 304-306
5. Lafaurie M.M., Grossman D., Troncoso E., Billings D.L., and Chávez S. Women's perspectives on medical abortion in Mexico, Colombia, Ecuador and Peru: a qualitative study. Reprod Health Matt 13 (2005) 75-83
6. Clark W., Gold M., Grossman D., and Winikoff B. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception 75 (2007) 245-250
7. Thonneau P., Fougeyrollas B., and Spira A. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center. Fertil Steril 61 (1994) 627-631
8. Walker K., Schaff E., Fielding S., and Fuller L. Monitoring serum chorionic gonadotropin levels after mifepristone abortion. Contraception 64 (2001) 271-273
9. Honkanen H., Ranta S., Ylikorkala O., and Heikinheimo O. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod 17 (2002) 2315-2319
10. Schaff E.A., Eisinger S.H., Franks P., and Kim S.S. Methotrexate and misoprostol for early abortion. Fam Med 28 (1996) 198-203
11. Grossman D., Ellertson C., Grimes D.A., and Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 103 (2004) 738-745
12. Godfrey E.M., Anderson A., Fielding S.L., Meyn L., and Creinin M.D. Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. Contraception 75 (2007) 378-382
13. Clinical Calculator 1. From an observed sample: estimates of population prevalence, sensitivity, specificity, predictive values, and likelihood ratios. Available at:. http://faculty.vassar.edu/lowry/clin1.html [Accessed 15 March 2006]
14. Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception 67 (2003) 463-465
15. Jain J.K., Dutton C., Harwood B., Meckstroth K.R., and Mishell Jr. D.R. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 17 (2002) 1477-1482
16. Sherris J., Bingham A., Burns M.A., Girvin S., Westley E., and Gomez P.I. Misoprostol use in developing countries: results from a multicountry study. Int J Gynaecol Obstet 88 (2005) 76-81